Group One Trading
VCNX

Group One Trading’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Group One Trading’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67
Closed -$231 – 8130
2024
Q3 		$231 Hold
67
– – ﹤0.01% 6447
2024
Q2 		$438 Hold
67
– – ﹤0.01% 6465
2024
Q1 		$496 Buy
67
+2
+3% +$17 ﹤0.01% 6739
2023
Q4 		$609 Hold
65
– – ﹤0.01% 7061
2023
Q3 		$1.03K Sell
65
-17
-21% -$864 ﹤0.01% 7206
2023
Q2 		$6.13K Sell
82
-7
-8% -$582 ﹤0.01% 6628
2023
Q1 		$7.46K Sell
89
-11
-11% -$1.21K ﹤0.01% 6102
2022
Q4 		$13.5K Hold
100
– – ﹤0.01% 5864
2022
Q3 		$10K Buy
100
+74
+285% +$14.5K ﹤0.01% 6525
2022
Q2 		$6K Buy
26
+3
+13% +$767 ﹤0.01% 7047
2022
Q1 		$6K Buy
23
+17
+283% +$4.7K ﹤0.01% 7414
2021
Q4 		$1K Buy
+6
New +$2.16K ﹤0.01% 8055
2021
Q1 		– Hold
0
– – – 8128
2020
Q4 		– Hold
0
– – – 7113

Other funds holding VCNX

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Group One Trading's VCNX Position: Q4 2024 in Review

Group One Trading sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 67 shares — an estimated $231 sold.

Group One Trading first reported a position in VCNX in Q4 2021 and held it in 12 quarters. The position peaked at $13.5K in Q4 2022. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.

  • Group One Trading reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 67 Vaccinex, Inc. Common Stock shares in Q4 2024, an estimated $231.
  • Group One Trading first reported a position in Vaccinex, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Group One Trading's Vaccinex, Inc. Common Stock position peaked at $13.5K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.